{
    "clinical_study": {
        "@rank": "3114", 
        "arm_group": [
            {
                "arm_group_label": "DES", 
                "description": "Patients who received a DES stent > 3 years ago."
            }, 
            {
                "arm_group_label": "BMS", 
                "description": "Patients who received BMS stents > 3 years ago."
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to test the hypothesis that plaque composition differs within a stent\n      between bare metal stents and drug eluting stents (DES). It is possible that a difference in\n      plaque composition seen within a stent may be contributory to the late thrombotic events\n      seen more frequently with DES."
        }, 
        "brief_title": "Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation", 
        "condition": "In-stent Coronary Artery Restenosis", 
        "condition_browse": {
            "mesh_term": "Coronary Restenosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject > 18 years of age;\n\n          -  Subject, male or female, who underwent DES or BMS implantation in a native coronary\n             vessel more than 3 year ago;\n\n          -  Subject is scheduled for a diagnostic coronary or interventional procedure;\n\n          -  Subject is willing to sign the informed consent.\n\n        Exclusion Criteria:\n\n          -  Subject requires emergency catheterization;\n\n          -  Subject has an acute myocardial infarction defined as anginal symptoms with\n             ST-elevation on the EKG or creatine kinase-MB elevation >3times the upper limit of\n             normal;\n\n          -  Angiographic evidence of \u2265 70% stenosis within the target stent (visual estimate);\n\n          -  Subject presented with cardiogenic shock;\n\n          -  Subject has angiographically confirmed thrombus in the target coronary artery;\n\n          -  Subject has a complex lesion not amenable to the IVUS/VH catheters and/or OCT\n             catheters passing the stented segment;\n\n          -  Subject has a contraindication to angiography/IVUS/OCT;\n\n          -  Female subject is pregnant or lactating;\n\n          -  Subject has life threatening comorbid conditions for which the investigator feels the\n             subject should not be enrolled"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "A total of 40 subjects will be enrolled in the study, with 20 patients who previously\n        received BMS > 3 years ago and 20 patients who previously received DES > 3 years ago"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835301", 
            "org_study_id": "IntraStent"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 31, 2013", 
        "location": {
            "contact": {
                "email": "ron.waksman@medstar.net", 
                "last_name": "Ron Waksman, MD", 
                "phone": "202-877-5975"
            }, 
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20010"
                }, 
                "name": "Medstar Washington Hospital Center"
            }, 
            "investigator": {
                "last_name": "Ron Waksman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation", 
        "overall_official": {
            "affiliation": "Medstar Washington Hospital Center", 
            "last_name": "Ron Waksman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "This study aims to test the hypothesis that plaque composition differs within the stent between BMS and DES. It is possible that a difference in plaque composition seen within the stent may be contributory to the late thrombotic events seen more frequently with DES.", 
            "measure": "Plaque composition", 
            "safety_issue": "No", 
            "time_frame": "During hospital stay, about 2 days."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835301"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medstar Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medstar Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}